Aventis Pharmaceuticals Inc. and Andrx Corp.

A class action was filed against the companies for antitrust violations of Cardizem CD. The case alleged Hoechst, a pharmaceutical company acquired by Aventis in 2000, paid Andrx not to market a generic version of the drug. The delay of the generic form caused consumers, medical insurance companies, and the government to buy the higher priced, brand name drug for an extra year. Aventis has agreed to a $24 million settlement that covers consumers who bought the drug between January 1998 and January of 2003. (Jul-05-05) [NASHVILLE BUSINESS JOURNAL]

[More Settlement Information]

Legal Help

If you have a similar problem and would like to be contacted by a lawyer at no obligation, please fill in our form to submit your complaint.